Amy Jo Sterling

Array ( [id] => 4295129 [patent_doc_number] => 06197744 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-06 [patent_title] => 'Tumor necrosis factor inhibitory protein tip B1 and method of using same' [patent_app_type] => 1 [patent_app_number] => 9/157910 [patent_app_country] => US [patent_app_date] => 1998-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 44 [patent_no_of_words] => 7789 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/197/06197744.pdf [firstpage_image] =>[orig_patent_app_number] => 157910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4393395 [patent_doc_number] => 06297022 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-02 [patent_title] => 'Method of identifying agonists and antagonists for tumor necrosis related receptor TR1' [patent_app_type] => 1 [patent_app_number] => 9/153927 [patent_app_country] => US [patent_app_date] => 1998-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8658 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/297/06297022.pdf [firstpage_image] =>[orig_patent_app_number] => 153927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4323562 [patent_doc_number] => 06329169 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Nucleic acid molecules encoding cytostatin II' [patent_app_type] => 1 [patent_app_number] => 9/043646 [patent_app_country] => US [patent_app_date] => 1998-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 18846 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/329/06329169.pdf [firstpage_image] =>[orig_patent_app_number] => 043646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1535811 [patent_doc_number] => 06337194 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-08 [patent_title] => 'Method for the preparation of insulin by cleavage of a fusion protein and fusion proteins containing insulin A and B chains' [patent_app_type] => B1 [patent_app_number] => 08/981988 [patent_app_country] => US [patent_app_date] => 1998-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 11951 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/337/06337194.pdf [firstpage_image] =>[orig_patent_app_number] => 08981988 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636296 [patent_doc_number] => 06380363 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Antibodies to the Ob receptor' [patent_app_type] => B1 [patent_app_number] => 09/137132 [patent_app_country] => US [patent_app_date] => 1998-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 40 [patent_no_of_words] => 60789 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/380/06380363.pdf [firstpage_image] =>[orig_patent_app_number] => 09137132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1489898 [patent_doc_number] => 06416973 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-09 [patent_title] => 'Nucleic acids encoding mammalian cell membrane protein MDL-1' [patent_app_type] => B1 [patent_app_number] => 09/127946 [patent_app_country] => US [patent_app_date] => 1998-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34066 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/416/06416973.pdf [firstpage_image] =>[orig_patent_app_number] => 09127946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1585935 [patent_doc_number] => 06358916 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-19 [patent_title] => 'Biological activity of IGF-I E domain peptide' [patent_app_type] => B1 [patent_app_number] => 09/120818 [patent_app_country] => US [patent_app_date] => 1998-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6370 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/358/06358916.pdf [firstpage_image] =>[orig_patent_app_number] => 09120818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1148584 [patent_doc_number] => 06770444 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-03 [patent_title] => 'Methods of identifying or screening for agents that binds the Ob-Re' [patent_app_type] => B2 [patent_app_number] => 09/116676 [patent_app_country] => US [patent_app_date] => 1998-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 23 [patent_no_of_words] => 21542 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/770/06770444.pdf [firstpage_image] =>[orig_patent_app_number] => 09116676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 963546 [patent_doc_number] => 06949358 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-09-27 [patent_title] => 'Human tumor necrosis factor receptor TR9' [patent_app_type] => utility [patent_app_number] => 09/095094 [patent_app_country] => US [patent_app_date] => 1998-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 34485 [patent_no_of_claims] => 88 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/949/06949358.pdf [firstpage_image] =>[orig_patent_app_number] => 09095094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4346460 [patent_doc_number] => 06214580 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Human tumor necrosis factor receptor tr10' [patent_app_type] => 1 [patent_app_number] => 9/086483 [patent_app_country] => US [patent_app_date] => 1998-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 21445 [patent_no_of_claims] => 109 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/214/06214580.pdf [firstpage_image] =>[orig_patent_app_number] => 086483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1527860 [patent_doc_number] => 06479255 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-12 [patent_title] => 'Polynucleotides encoding human FRP and fragments thereof' [patent_app_type] => B1 [patent_app_number] => 09/087031 [patent_app_country] => US [patent_app_date] => 1998-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 20 [patent_no_of_words] => 21310 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/479/06479255.pdf [firstpage_image] =>[orig_patent_app_number] => 09087031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1493975 [patent_doc_number] => 06342369 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-29 [patent_title] => 'Apo-2-receptor' [patent_app_type] => B1 [patent_app_number] => 09/079029 [patent_app_country] => US [patent_app_date] => 1998-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 34 [patent_no_of_words] => 36612 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/342/06342369.pdf [firstpage_image] =>[orig_patent_app_number] => 09079029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1576811 [patent_doc_number] => 06447783 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-10 [patent_title] => 'Compositions comprising FGF9 and use thereof for stimulating cartilage and bone repair' [patent_app_type] => B1 [patent_app_number] => 08/981030 [patent_app_country] => US [patent_app_date] => 1998-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 16 [patent_no_of_words] => 6607 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/447/06447783.pdf [firstpage_image] =>[orig_patent_app_number] => 08981030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1212449 [patent_doc_number] => 06709838 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-23 [patent_title] => 'Nucleic acid encoding patched-2' [patent_app_type] => B1 [patent_app_number] => 09/060939 [patent_app_country] => US [patent_app_date] => 1998-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 32 [patent_no_of_words] => 37174 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/709/06709838.pdf [firstpage_image] =>[orig_patent_app_number] => 09060939 [rel_patent_id] =>[rel_patent_doc_number] =>)